Skip to content
Catalyst

PapersPMID:39854533

Effects of Cinnamomum zeylanicum (Ceylon cinnamon) extract on lipid profile, glucose levels and its safety in adults: A randomized, double-blind, controlled trial.

PloS one2025The record ↗

  1. Finding, moderate evidenceno difference foundLDL cholesterol

No finding here moved its endpoint.

What did not

1 findingHow to read these marks →
  • “Of the 127 participants with a 12 week assessment, those in the C. zeylanicum arm had a lower LDL-C value than the placebo arm but the difference was not significant (the baseline adjusted mean difference was 6.05 mg/dL; 95% CI: -2.43 to 14.52; p = 0.161; Table 2).”
    Study
    RCT
    Participants
    127
    Duration
    3 months
    Effect
    6.05 mean difference, 95% CI −2.43 to 14.52
    Interests
    Industry funded
    Dose studied
    two 500 mg capsules per day (1000 mg/day), one before breakfast and one before dinner, for 12 weeks
    Population
    Sri Lankan adults aged 18 to 70 with LDL-C between 100 and 190 mg/dL, not on statins or other lipid-lowering drugs

Study record

Design
randomised controlled trial
Species
human
Population
adults aged 18 to 70 years with LDL-C between 100 and 190 mg/dL, Sri Lanka
Participants
150
Comparator
placebo
Duration
84 days
Endpoints measured
38